Gricourt Yann, Boulos Nancy M, Delaporte Amelie, Alexander Brenton, Besada Stephane, Bakhit Ryan, Toukhtarian Aline, Neuman Ido, Pearce Daniel, Nourian Meziar M, Chebishian Arthur, Zhou Amy, Boktor Janice, Mayanja Dylan, Grogan Tristan, Boldt David, Cannesson Maxime, Forget Patrice, Joosten Alexandre
Department of Anesthesiology and Perioperative Medicine, David Geffen School of Medicine, University of California Los Angeles, CA, USA.
Department of Anesthesiology and Perioperative Medicine, Nimes University Hospital, Nimes, France.
BJA Open. 2025 Jun 18;15:100420. doi: 10.1016/j.bjao.2025.100420. eCollection 2025 Sep.
Although opioids are commonly used to relieve pain associated with surgery, they are not consequence free. Moreover, the USA and many western countries are currently experiencing a significant health crisis because of opioid addiction and its related overdose potential. There have been no studies that have evaluated patient preference regarding opioid use and its potential impact on the quality of recovery. The aim of this study is to compare the effect of patient preference on intraoperative opioid use on early postoperative quality of recovery after moderate risk laparoscopic/robotic abdominal surgery.
This trial is an interventional, pragmatic, partially randomised factorial trial. Adults (=240) scheduled for moderate-risk abdominal surgery under laparoscopic/robotic assistance (colorectal, urologic, and gynaecologic) will be allocated into four groups, according to their preference (choice of opioid-free opioid-based anaesthesia no choice and, if no choice, then the patient is randomised to opioid-based opioid-free anaesthesia). Anaesthesia providers and patients who choose their anaesthesia type will be unblinded of the allocation group. The primary endpoint will be the Quality of Recovery-15 score at postoperative day 1. Secondary endpoints will include patient satisfaction, postoperative nausea and vomiting, intraoperative bradycardia, postoperative opioid consumption, postoperative hypoxemia, and health-related quality of life using the EuroQoL 5-Dimension 5-Level (EQ-5D-5L).
This trial will provide evidence on whether patient preference on intraoperative opioid use can improve patient quality of recovery after moderate-risk abdominal surgery.
NCT06855641.
2.0, 24 February 2025.
尽管阿片类药物常用于缓解手术相关疼痛,但并非毫无后果。此外,美国和许多西方国家目前正因阿片类药物成瘾及其相关的过量用药风险而面临严重的健康危机。尚无研究评估患者对阿片类药物使用的偏好及其对恢复质量的潜在影响。本研究的目的是比较患者对术中阿片类药物使用的偏好对中度风险腹腔镜/机器人腹部手术后早期恢复质量的影响。
本试验是一项干预性、务实性、部分随机析因试验。计划在腹腔镜/机器人辅助下进行中度风险腹部手术(结直肠、泌尿和妇科)的成年人(=240名)将根据其偏好分为四组(选择无阿片类药物 基于阿片类药物的麻醉 无选择,若无选择,则将患者随机分为基于阿片类药物 无阿片类药物麻醉)。选择麻醉类型的麻醉医生和患者将知晓分组情况。主要终点将是术后第1天的恢复质量-15评分。次要终点将包括患者满意度、术后恶心呕吐、术中心动过缓、术后阿片类药物消耗量、术后低氧血症以及使用欧洲五维健康量表5级(EQ-5D-5L)评估的健康相关生活质量。
本试验将提供证据,证明患者对术中阿片类药物使用的偏好是否能改善中度风险腹部手术后的患者恢复质量。
NCT06855641。
2.0,2025年2月24日。